Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Actuate Therapeutics, Inc. (ACTU) had Normalized Pre-Tax Income of $-4.87M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.87M |
|
-- |
|
-- |
|
$4.91M |
|
$-4.91M |
|
$0.04M |
|
$-4.87M |
|
|
Normalized Pre-Tax Income |
$-4.87M |
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.87M |
|
$-4.91M |
|
$-4.91M |
|
23.87M |
|
23.87M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$4.75M |
|
-- |
|
$0.45M |
|
$5.20M |
|
$3.81M |
|
-- |
|
$0.41M |
|
$4.21M |
|
$0.99M |
|
$0.99M |
|
$0.99M |
|
24.01M |
|
| Cash Flow Statement Financials | |
$-9.42M |
|
-- |
|
$0.69M |
|
$13.16M |
|
$4.43M |
|
$-8.73M |
|
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-491.99% |
|
-492.00% |
|
-93.60% |
|
-492.00% |
|
$0.04 |
|
$-0.39 |
|
$-0.39 |
|